Concepedia

Author

Sarita D. Boyd

Center for Drug Evaluation and ResearchORCID

Also Known As

S D Boyd, S. D. Boyd, Safia Kuriakose, Sarita Boyd, Sarita D Boyd, Sarita D. Boyd

12

Publications

351

Citations

10

H-Index

18

Concepts

All Affiliations

Center for Drug Evaluation and ResearchNational Institutes of HealthNational Institute of Allergy and Infectious DiseasesScience Applications International Corporation (United States)United States Food and Drug Administration
SD

About

Sarita D. Boyd is an author at Center for Drug Evaluation and Research specializing in medicine, hepatitis c, and virology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

114

2

Epidemiology

2

2

66

3

Hepatology

2

2

24

4

Public Health

1

1

36

5

Obstetrics

1

1

36

Sarita D. Boyd

×

8

Publications

245

Citations

8

H-Index

YearCitations

Transmitted Raltegravir Resistance in An HIV-1 Crf_Ag-Infected Patient

Sarita D. Boyd, Frank Maldarelli, Irini Sereti,

Antiviral Therapy

2011

70

Regulatory Analysis of Effects of Hepatitis C Virus NS5A Polymorphisms on Efficacy of Elbasvir and Grazoprevir

Takashi Komatsu, Sarita D. Boyd, Adam Sherwat,

Gastroenterology

2016

54

Influence of Low-Dose Ritonavir With and Without Darunavir on the Pharmacokinetics and Pharmacodynamics of Inhaled Beclomethasone

Sarita D. Boyd, Colleen Hadigan, Maryellen McManus,

JAIDS Journal of Acquired Immune Deficiency Syndromes

2013

38

Cobicistat-containing antiretroviral regimens are not recommended during pregnancy

Sarita D. Boyd, Mario R. Sampson, Prabha Viswanathan,

AIDS

2019

36

Recognition and Management of Significant Drug Interactions in HIV Patients: Challenges in Using Available Data to Guide Therapy

Alice K. Pau, Sarita D. Boyd

Clinical Pharmacology & Therapeutics

2010

13

US FDA Perspective on Elbasvir/Grazoprevir Treatment for Patients with Chronic Hepatitis C Virus Genotype 1 or 4 Infection

Sarita D. Boyd, LaRee Tracy, Takashi Komatsu,

Clinical Drug Investigation

2017

12

<scp>HCV</scp> genotype 4, 5 and 6: Distribution of viral subtypes and sustained virologic response rates in clinical trials of approved direct‐acting antiviral regimens

Sarita D. Boyd, Patrick R. Harrington, T. Komatsu,

Journal of Viral Hepatitis

2018

12

Impaired Maraviroc and Raltegravir Clearance in a Human Immunodeficiency Virus–Infected Patient with End‐Stage Liver Disease and Renal Impairment: A Management Dilemma

Alice K. Pau, Scott Penzak, Sarita D. Boyd,

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy

2012

10

Page 1